EquityZen Growth Technology Fund LLC - Series 1850
Raised
$267K
Investors
17
Min Invest
$10,003
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1850 is a Delaware pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett, raising $267K from 17 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This series is part of the EquityZen platform, which operates 1889+ related EDGAR entities focused on pre-IPO secondary transactions.
This pre-IPO fund follows the standard EquityZen structure: individual series vehicles with low minimums ($10K) and small investor counts, enabling retail access to late-stage private company shares. The 506(b) exemption and 3(c)(1) registration exemption are typical for sub-100 investor pooled funds in this category.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.